Login

Reload

Remember me Forgot it?

Not a subscriber?

Click on the button below to create your account and get immediate access to Xinhua Silk Road Database.

Start a Free Trial

Subscribe

Belt & Road Weekly Subscription Form

Research Report

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

companies

HOME > Company


Evergrande Health Industry (0708.HK) buys 51pct stake in NEVS for USD930 mln

January 16, 2019


Abstract : Evergrande Health Industry Group Limited (0708.HK) announced on Tuesday to buy a 51-percent stake in National Electric Vehicle Sweden AB (NEVS) for 930 million U.S. dollars.

BEIJING, Jan. 16 (Xinhua) -- Evergrande Health Industry Group Limited (0708.HK) announced on Tuesday to buy a 51-percent stake in National Electric Vehicle Sweden AB (NEVS) for 930 million U.S. dollars.

According to a filing to the stock exchange, the 930 million U.S. dollars will be paid in two instalments. Specifically, the first instalment of 430 million U.S. dollars had been paid on January 15, 2019, and the remaining amount shall be paid on or before 31 January 2019.

Meanwhile, the listed company will obtain a majority of board seats on the NEVS board of directors, after the transaction.

NEVS, with its headquarters based in Sweden, is a global electric vehicle company focused on intelligent automobiles and is striving to become a global leader in sustainable and sharing-based smart mobility ecosystems.

NEVS, as one of the ten qualified new energy automobile companies currently approved by the National Development and Reform Commission (NDRC) and the Ministry of Industry and Information Technology (MIIT), has developed two pure electric vehicle models that have reached production standards. It also owns production bases in Trollhättan, Sweden and Tianjin, China, which have mass production capabilities and is planning to develop a production base in Shanghai. (Edited by Hu Pingchao, hupingchao@xinhua.org)


Related Coverage

Focus

Think Tank

  • 'Make in India' and 'Made in China' not zero-sum gam...

    March 1, 2019

    The success "Make in India" initiative will not only be conducive to the de...

  • The fledgling Greater Bay Area needs ‘affable guida...

    February 28, 2019

    From the examples of three bay areas, namely New York, San Francisco and Tok...

  • Economy can resist external pressure

    February 28, 2019

    China is capable of dealing with any pressure because it is committed to dee...

  • Household debt ratio not a cause for concern

    February 26, 2019

    For many families, the mortgage payment to household income ratio is unreaso...

  • Ask Us A Question

    If you have any questions, please enter them in the box below.

    Reload

    Write to Us

    Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

    Click on the button below to create your account and get imhttp://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

    Start a Free Trial